Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) ROA

Celldex Therapeutics, Inc. (CLDX) ROA

  • 2026-06-30: ROA -38.42%.
  • 2026-03-31: ROA -55.48%.
  • 2025-12-31: ROA -44.38%.
  • 2025-09-30: ROA -34.63%.

Complete source-backed roa history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-38.42%
2026-03-31-55.48%
2025-12-31-44.38%
2025-09-30-34.63%
2025-06-30-28.83%
2025-03-31-24.19%
2024-12-31-19.92%
2024-09-30-14.70%
2024-06-30-10.46%

Annual ROA

DateROA
2025-12-31-44.38%
2024-12-31-19.92%
2023-12-31-30.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93